Upadacitinib User Survey Confirms Eczema Clinical Data

About 28% of respondents reported itch improvement within 1 day of taking the drug.
Medscape Medical News

source https://www.medscape.com/viewarticle/survey-spotlights-real-world-experience-upadacitinib-atopic-2024a1000bfu?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost